Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
72.1 CHF | -0.55% | -3.61% | +41.65% |
06-03 | Cosmo Pharmaceuticals Swings to Loss in FY23; Revenue Down | MT |
04-26 | Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.65% | 1.3B | |
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B |
- Stock Market
- Equities
- COPN Stock
- News Cosmo Pharmaceuticals N.V.
- Transcript : Cosmo Pharmaceuticals N.V., H1 2022 Earnings Call, Jul 28, 2022